CoChat

Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

Abstract

Creatine is of paramount importance for maintaining and managing cellular ATP stores in both physiological and pathological states. Besides these "ergogenic" actions, it has a number of additional "pleiotropic" effects, e.g., antioxidant activity, neurotransmitter-like behavior, prevention of opening of mitochondrial permeability pore and others. Creatine supplementation has been proposed for a number of conditions, including neurodegenerative diseases. However, it is likely that creatine's largest therapeutic potential is in those diseases caused by energy shortage or by increased energy demand; for example, ischemic stroke and other cerebrovascular diseases. Surprisingly, despite a large preclinical body of evidence, little or no clinical research has been carried out in these fields. However, recent work showed that high-dose creatine supplementation causes an 8-9 % increase in cerebral creatine content, and that this is capable of improving, in humans, neuropsychological performances that are hampered by hypoxia. In addition, animal work suggests that creatine supplementation may be protective in stroke by increasing not only the neuronal but also the endothelial creatine content. Creatine should be administered before brain ischemia occurs, and thus should be given for prevention purposes to patients at high risk of stroke. In myocardial ischemia, phosphocreatine has been used clinically with positive results, e.g., showing prevention of arrhythmia and improvement in car…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00726-016-2173-8

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 108 references

Research works printed but not linked: 6

  1. Coraggio F, Spina M, Scarpato P (1987) Analysis of creatine phosphate on the evolution of ischemic lesion in acute myocardial infarction. Farmaci Terapia 4:91–93
  2. Ingwall JS (1993) Is cardiac failure a consequence of decreased energy reserve? Circulation 87:58–62
  3. Iosseliani DG, Koledinsky AG, Kuchkina NV (2004) Does intracoronary injection of phosphocreatine prevent myocardial reperfusion injury following angioplasty of infarct-related artery in acute-stage of myocardial infarction? J Intervent Cardiol 6:10–14
  4. Iosseliani DG, Koledinsky AG, Kuchkina NV (2006) The possibility to limit reperfusion injury of cardiomyocytes using intracoronary cytoprotectors during endovascular reperfusion of the infarct-related artery. J Intervent Cardiol 11:10–16
  5. Raisaro A, Bargiggia CS, Bertucci C (1989) Clinical evaluation of phosphocreatine effect during acute myocardial infarction: A multicenter study: 139147. Proceedings of the International Meeting “Cardioprotection with phosphocreatine in cardiology and cardiac surgery” IRCCS, Policlinico S. Matteo, Università degli studi, Pavia
  6. Skřivánek O, Kalvach Pavel, Benetin Ján, Brzák M, Kukumberg I, Strnad P, Strnadová V, Traubner Pavol, Turčány P, Vávra P (1995) Waberžinek, Gerhard. Kreatinfosfát v léčbě akutních ischemických iktů. Prakticky Lekar 75:7–8

Cited by

See all 61

Metadata

Authors
Balestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P.
Affiliations
University of Genoa (IT)
Corresponding author
Balestrino, Maurizio
Venue
Amino Acids
Published
2016-01-21
Volume
48
Issue
8
Pages
1955-1967
ISSN
  • 0939-4451 (ISSN-L)
  • 1438-2199
OpenAlex
W2275117202
Cited by
60
References
108
Citations by year
2026: 2 · 2025: 8 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 2 · 2016: 4
FWCI
0.50
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Amino Acids (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Funders
Telethon Italy (GEP 13019)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
Keywords
creatine supplementation, phosphocreatine, cerebrovascular disease, ischemic stroke, ischemic heart disease, myocardial ischemia, hypoxia, antioxidant activity, cardioplegic solution, arrhythmia prevention, reperfusion
MeSH terms
Animals, Hypoxia, Brain, Humans, Phosphocreatine, Myocardial Ischemia, Dietary Supplements, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. https://app.cochat.ai/papers/10.1007/s00726-016-2173-8
The paper
Balestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P. (2016). Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. Amino Acids. https://doi.org/10.1007/s00726-016-2173-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.